Clinical Trials on Advanced Kidney Cancer in Switzerland

Total 1117 results

Eli Lilly and Company

Completed

C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors

Advanced Cancer

Switzerland
School of Health Sciences Geneva
University Hospital, Geneva; Krebsforschung Schweiz, Bern, Switzerland

Completed

Impact of a Resource-based Life Review Intervention on Advanced Cancer Patients (Revie⊕)

Advanced Cancer

Switzerland
Cantonal Hospital of St. Gallen

Completed

Romanian-Swiss Research Programme IZERZO (IZERZO)

Advanced Incurable Cancer

Switzerland, Romania
University Hospital, Basel, Switzerland
Kantonsspital Olten

Completed

Surgical Procedures for Advanced Tumor Disease. A Prospective Study Evaluating Quality of Life

Advanced Cancer

Switzerland
University Hospital Inselspital, Berne
Swiss National Science Foundation; University of Bern

Unknown

A Structured Early Palliative Care Intervention for Patients With Advanced Cancer - a Randomized Controlled Trial With a Nested Qualitative Study (SENS Trial) (SENS)

Advanced Cancer

Switzerland
TOLREMO therapeutics AG

Recruiting

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of TT125-802 in Subjects With Advanced Solid Tumors (TT-CSP-001)

Cancer | Adult Solid Tumor | Advanced Solid Tumor | Adult Disease

Spain, Switzerland
University of Zurich
University Hospital, Geneva; University Hospital Inselspital, Berne; University... and other collaborators

Completed

Cancer Development In Organ Transplant Recipients

Kidney Cancer | Lung Cancer | Pancreas Cancer | Liver Cancer | Heart Cancer

Switzerland
Apeiron Biologics

Completed

Safety and Tolerability Study of APN01 (Recombinant Human Angiotensin Converting Enzyme 2)

Cardiovascular Diseases | Kidney Diseases | Pulmonary Diseases | Cancer Diseases

Switzerland
Thomas Zilli
University Hospital, Geneva

Terminated

Organ-sparing With TraceIT® for Rectal Cancer Radiotherapy

Rectal Cancer | Advanced Cancer | Rectal Tumors

Switzerland
Dimitri Christoforidis
Clinical Trial Unit Ente Ospedaliero Cantonale

Terminated

Observational Study on Rectal Cancer to Verify if Response After Chemo-radiotherapy Can be Predicted With a Particular Blood Test. (LiBReCa)

Locally Advanced Rectal Cancer

Switzerland
PIQUR Therapeutics AG

Completed

A Study to Investigate Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of PQR309

Advanced Solid Tumors

Switzerland
University Hospital, Basel, Switzerland

Not yet recruiting

Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors (ISCA-CHECK)

Advanced Solid Tumor

Switzerland
Southern Europe New Drug Organization
Pierre Fabre Laboratories; Agennix

Unknown

Satraplatin and Vinorelbine in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
Bristol-Myers Squibb

Active, not recruiting

An Investigational Study of Immunotherapy Combinations in Participants With Solid Cancers That Are Advanced or Have Spread

Advanced Cancer

France, United States, Spain, Australia, Italy, Switzerland, United Kingdom
Thomas Mueller

Unknown

Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal Function

Kidney Neoplasms | Adult Polycystic Kidney Disease | Kidney Dysfunction

Switzerland
Kantonsspital Winterthur KSW

Completed

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program

Renal Cell Carcinoma | Breast Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Urothelial Carcinoma | Pleural Mesothelioma | Gastro-Intestinal Cancer

Switzerland
Cantonal Hospital of St. Gallen
Bachem

Completed

Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study

Cachexia | Advanced Cancer

Switzerland
University Hospital, Basel, Switzerland
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Calcineurin Free Immunosuppression in Renal Transplant Recipients

Chronic Kidney Disease | Kidney Transplantation

Switzerland
Southern Europe New Drug Organization
Novartis

Unknown

LBH589 Oral in Combination With Carboplatin and Paclitaxel in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
Southern Europe New Drug Organization
Celgene Corporation

Unknown

Lenalidomide and Paclitaxel in Advanced Solid Tumors

Advanced Solid Tumors

Switzerland, Italy
Southern Europe New Drug Organization
Novartis; Schering-Plough

Unknown

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Italy, Switzerland
University of Zurich

Completed

Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Switzerland
Novartis Pharmaceuticals

Completed

Pharmacokinetic Drug-drug Interaction Study of Dovitinib (TKI258) in Patients With Advanced Solid Tumors. (CTKI258A2120)

Advanced Solid Tumors, Excluding Breast Cancer

Netherlands, Switzerland, Denmark, United States
University of Zurich

Unknown

Extracorporal Shockwave Lithotripsy Versus Retrograde Intrarenal Surgery for the Treatment of Kidney Stones

Kidney Stones

Switzerland
TheraOp
AstraZeneca

Active, not recruiting

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC (PACCELIO)

Stage III Non-small Cell Lung Cancer | Locally Advanced | Unresectable

Switzerland
University Hospital, Basel, Switzerland
Sanofi; Roche Pharma AG; Swiss National Science Foundation; Swiss Cancer League

Completed

Gemcitabine, Oxaliplatin and Capecitabine for Advanced Pancreatic Carcinoma (GEMOXEL)

Metastatic Pancreatic Cancer | Locally Advanced Pancreatic Cancer

Switzerland
University Hospital Inselspital, Berne
Bern University of Applied Sciences

Terminated

Whole-body Vibration Physiotherapy in Kidney Transplantation

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Cyclosporine Microemulsion and Steroids in Pediatric de Novo Renal Transplant Patients

Kidney Transplantation

Switzerland
University Hospital, Basel, Switzerland

Completed

Comparison of ATG to Thymoglobuline in Renal Transplantation

Transplantation, Kidney

Switzerland
Novartis

Completed

Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients

Kidney Transplantation

Switzerland
University Hospital, Basel, Switzerland

Completed

Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

Kidney Transplantation

Switzerland
Novartis Pharmaceuticals

Withdrawn

Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients (HERMES)

Kidney Transplantation

Switzerland
Novartis

Completed

Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients

Kidney Transplantation

Switzerland
PharmaMar

Completed

Study of Lurbinectedin (PM01183) in Combination With Cisplatin in Patients With Solid Tumors

Advanced Solid Tumors

United Kingdom, Switzerland
Novartis

Completed

Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients (OLYMPE)

Kidney Diseases

Switzerland
University of Zurich

Unknown

The Role Of FGF23, Klotho, And Sclerostin In Kidney Stone Formers

Kidney Stones

Switzerland
Bristol-Myers Squibb

Terminated

First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors

Advanced Cancer

Chile, United States, Argentina, Australia, Belgium, Canada, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Switzerland
Markus Joerger
University of Basel

Completed

Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients

Non Small-cell Lung Cancer | Renal-cell Cancer | Gastrointestinal Stroma Tumor

Switzerland
University Hospital Inselspital, Berne
Boehringer Ingelheim; University of Bern

Completed

Impact of the SGLT2 Inhibitor Empagliflozin on Urinary Supersaturations in Kidney Stone Formers (SWEETSTONE)

Kidney Stone

Switzerland
Cantonal Hospital Graubuenden
University of Zurich

Not yet recruiting

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease (SIDIA)

Autosomal Dominant Polycystic Kidney Disease

Switzerland
Centre Hospitalier du Centre du Valais
University of Lausanne Hospitals; Research Unit CHCVs Hôpital de Sion Switzerland and other collaborators

Unknown

Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

End-stage Kidney Disease | CD4 T Cells | Central Memory T Cells | Regulatory T Cells | Uremic Toxins

Switzerland
University of Zurich

Withdrawn

Does Terlipressin Improve Renal Outcome After Liver Surgery (TIROL)

Kidney Failure

Switzerland
Novartis

Completed

Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids

Kidney Transplantation | Adverse Effects

Switzerland
Novartis

Completed

Conversion Trial From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS) in Stable Transplanted Patients Suffering From Gastrointestinal (GI) Adverse Events While on Mycophenolate Mofetil Therapy (MMF) Therapy

Liver Transplantation | Kidney Transplantation

Switzerland
University Hospital, Basel, Switzerland
Swiss National Science Foundation

Completed

PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION

Kidney Failure, Acute

Switzerland, Italy
Swiss Group for Clinical Cancer Research

Recruiting

TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.

Lung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung Cancer

Switzerland
University Hospital Inselspital, Berne

Completed

Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT

Kidney Neoplasms | Cystic Renal Diseases

Switzerland
Novartis

Completed

Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients

Kidney Transplantation

Switzerland
Antea Foundation
Abbott Diabetes Care

Active, not recruiting

GLYPALCARE STUDY - Multicenter, Randomized Study for Evaluating Continuous Glucose Monitoring (CGM) by Using FreeStyle Libre 2 (FSL2) for Preventing Hyperglycemia/Hypoglycemia Crisis in Advanced Oncological Patients.

Diabetes Mellitus, Type 2 | Diabetes | Cancer | Diabetes Mellitus, Type 1 | Advanced Cancer | Palliative Care | Terminal Illness | End Stage Cancer | Terminal Cancer

Israel, Italy, Switzerland

Clinical Trials on Advanced Kidney Cancer in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations